Reich Kristian
SEC CIK 1920553 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | CSO | 2.71M | — | $19.54M | 26 | 2023-04-05 | 2026-07-27 |
Most active insiders at MLTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BVF PARTNERS L P/IL | Dir, 10% | — | $62.96M |
| 2 | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | — | $46.87M |
| 3 | Santos da Silva Jorge | CEO, Dir | — | $8.73M |
| 4 | Reich Kristian | CSO | — | $8.14M |
| 5 | Bodenstedt Matthias | CFO | $98.8K | $3.20M |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2026-07-29 16:10 | 2026-07-27 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $20.00 | -1,100 | 2.71M | -0.0% | -$22.0K |
| MTI | 2026-07-23 16:05 | 2026-07-21+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $20.02 | -52.4K | 2.71M | -2% | -$1.05M |
| TI | 2026-07-21 18:13 | 2026-07-20 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $20.09 | -43.7K | 2.76M | -2% | -$877.9K |
| TI | 2026-07-20 06:07 | 2026-07-15 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $20.01 | -16.1K | 2.81M | -0.6% | -$322.3K |
| MTI | 2026-06-17 18:15 | 2026-06-15+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $19.01 | -150.0K | 2.82M | -5% | -$2.85M |
| D | 2025-12-22 | 2025-12-19 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | D - Sale to Iss | — | -35.4K | 0 | -100% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | C - Cnv Deriv | — | +35.4K | 35.4K | New | — |
| M | 2025-12-10 | 2025-12-08+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $14.85 | -202.9K | 0 | -100% | -$3.01M |
| D | 2025-09-04 | 2025-09-02 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | D - Sale to Iss | — | -49.0K | 35.4K | -58% | — |
| D | 2025-09-04 | 2025-09-02 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | C - Cnv Deriv | — | +49.0K | 202.9K | +32% | — |
| D | 2025-01-22 | 2025-01-20 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | D - Sale to Iss | — | -111.9K | 84.4K | -57% | — |
| D | 2025-01-22 | 2025-01-20 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | C - Cnv Deriv | — | +111.9K | 153.9K | +267% | — |
| M | 2024-02-29 | 2024-02-27+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $55.00 | -57.5K | 70.1K | -45% | -$3.16M |
| MI | 2024-02-29 | 2024-02-27+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $55.00 | -61.4K | 2.93M | -2% | -$3.38M |
| MI | 2024-02-22 | 2024-02-20+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $57.35 | -10.5K | 2.99M | -0.4% | -$602.7K |
| M | 2024-02-22 | 2024-02-20+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $57.32 | -10.6K | 99.5K | -10% | -$605.8K |
| MI | 2024-02-16 | 2024-02-14+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $60.91 | -30.0K | 3.02M | -1.0% | -$1.83M |
| M | 2024-02-16 | 2024-02-14+ | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | S - Sale | $60.91 | -30.0K | 120.1K | -20% | -$1.83M |
| DI | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | D - Sale to Iss | — | -2.53M | 0 | -100% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | D - Sale to Iss | — | -42.0K | 196.3K | -18% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | C - Cnv Deriv | — | +42.0K | 140.1K | +43% | — |
| DI | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | C - Cnv Deriv | — | +2.53M | 3.03M | +505% | — |
| D | 2023-04-07 | 2023-04-05 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | D - Sale to Iss | — | -98.1K | 238.3K | -29% | — |
| D | 2023-04-07 | 2023-04-05 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | C - Cnv Deriv | — | +98.1K | 98.1K | New | — |
| DI | 2023-04-07 | 2023-04-05 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | C - Cnv Deriv | — | +500.0K | 500.0K | New | — |
| DI | 2023-04-07 | 2023-04-05 | MLTX | MoonLake Immunotherapeutics | Reich Kristian | CSO | D - Sale to Iss | — | -500.0K | 2.53M | -17% | — |
Purchase Sale Sale after option exercise All abbreviations